Abstract
OBJECTIVES The aim of this study was to test the hypothesis that commonly administered pediatric oral medications are a significant source of toxic elements. The concentrations of 16 elements were determined in 14 frequently used pediatric oral medications. METHODS Samples were prepared for analysis by dilution or nitric acid microwave-assisted digestion and analyzed by inductively coupled plasma mass spectrometry. The intake of each element from administration for 1 week of the medication’s maximum recommended daily dose to 6-month-olds was calculated and compared to an exposure guideline for that element. Exposure guidelines used for adverse effects were minimal risk levels, oral reference dose, permissible or permitted daily exposure, provisional tolerable weekly intake, and tolerable upper intake concentrations. Exposure guidelines utilized for desired effect were adequate intake and recommended dietary allowance.RESULTS Intake of the maximum recommended daily dose by 6-month-olds for 1 week would not deliver more than the exposure guideline of any of the elements, with the exceptions of chromium in several medications and zinc in the pediatric electrolyte solution, if it was consumed for 1 week. CONCLUSIONS Consumed alone, these frequently administered pediatric oral medications would not deliver amounts of toxic elements that exceed established exposure guidelines for adverse effects, nor would most significantly contribute to adequate intake of essential elements.
Original language | English |
---|---|
Pages (from-to) | 193-202 |
Number of pages | 10 |
Journal | Journal of Pediatric Pharmacology and Therapeutics |
Volume | 22 |
Issue number | 3 |
DOIs | |
State | Published - May 1 2017 |
Bibliographical note
Publisher Copyright:© Published by the Pediatric Pharmacy Advocacy Group. All rights reserved.
Funding
Summer Research Program support was provided to Sarah E. Seger by The Pharmaceutical Sciences Department and Office of the Dean, College of Pharmacy, University of Kentucky. The authors thank Kathleen M. Gura, PharmD, Children’s Hospital Boston, for making us aware of the information gap that this study addressed; Robert J. Kuhn, PharmD, College of Pharmacy, University of Kentucky, for helping us acquire the prescription drugs; and Shristi Shrestha, BS, for assistance with sample preparation and analysis. Summer Research Program support was provided to Sarah E. Seger by The Pharmaceutical Sciences Department and Office of the Dean, College of Pharmacy, University of Kentucky. The authors thank Kathleen M. Gura, PharmD, Children?s Hospital Boston, for making us aware of the information gap that this study addressed; Robert J. Kuhn, PharmD, College of Pharmacy, University of Kentucky, for helping us acquire the prescription drugs; and Shristi Shrestha, BS, for assistance with sample preparation and analysis.
Funders | Funder number |
---|---|
University of Kentucky | |
College of Pharmacy |
Keywords
- Aluminum
- Cadmium
- Lead
- Maximum allowable concentration
- Metals (heavy)
- Oral medications
- Pediatric
- Recommended dietary allowances
- Trace elements
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Pharmacology (medical)